The 7 analysts offering 1 year price forecasts for NATCOPHARM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to NATCOPHARM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NATCOPHARM EPS for the last quarter is 37.80 INR despite the estimation of 32.95 INR. In the next quarter EPS is expected to reach 1.90 INR. Track more of NATCO PHARMA LTD. financials and stay on top of what is up with the company.
In the next quarter NATCO PHARMA LTD. revenue is expected to reach 5.42 B INR. Check out NATCO PHARMA LTD. revenue and earnings and make informed decisions.
According to analysts, NATCOPHARM price target is 1,505.57 INR with a max estimate of 1,675.00 INR and a min estimate of 1,350.00 INR. Check if this forecast comes true in a year, meanwhile watch NATCO PHARMA LTD. stock price chart and keep track of the current situation with NATCOPHARM news and stock market news.
We've gathered opinions of 7 analysts rating NATCOPHARM stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.